![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
ImmBio gets Biomedical Catalyst support to develop pneumococcal vaccine PnuBioVax
Immunobiology (ImmBio), a UK-based biopharmaceutical company, has bagged £0.2m in funding from the UK...
Merck, Luminex collaborate to develop companion diagnostic device
Merck, referred to as MSD outside the US and Canada, and Luminex have signed...
Mylan Pharmaceuticals launches Fenofibrate Capsules
Mylan Pharmaceuticals, a subsidiary of global pharmaceutical company Mylan, has launched Fenofibrate Capsules USP,...
Ablynx inks deal with Spirogen to evaluate novel anti-cancer drug conjugate
Ablynx has signed a collaborative agreement with Spirogen to evaluate the potential of a...
UCB, ConfometRx sign drug discovery research deal
Belgium-based biopharmaceutical company UCB has signed a research deal with ConfometRx for the discovery...
Dr. Reddy’s introduces Desloratadine ODT in US
Dr. Reddy's Laboratories has received the FDA approval and introduced Desloratadine orally disintegrating tablets...
Stellar Biotechnologies develops aquaculture system for KLH manufacturing
Stellar Biotechnologies has developed a controlled, commercial-scale aquaculture system for fully sustainable Keyhole Limpet...
Synthon opens new GMP antibody-drug conjugate production facility in Nijmegen
Synthon Biopharmaceuticals has opened a GMP antibody-drug conjugate (ADC) production facility in Nijmegen. ...
Paladin introduces grass pollen allergy medication in Canada
Specialty pharmaceutical company Paladin Labs has introduced first allergen immunotherapy tablet, Oralair, against grass...
Aptar Pharma names Jean-Marc Pardonge as prescription division new president
Aptar Pharma, a subsidiary of Aptargroup, has named Jean-Marc Pardonge as the new president...